Burning Rock Biotech Limited (BNR)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$16.63
-12.75%
Mkt Cap $24.20M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | $17.81M | — | -$1.40 | -$0.21 | +84.97% | — | — |
| Q4 2025 Nov 20, 2025 | — | $18.49M | — | — | -$0.26 | — | — | — |
| Q3 2025 Sep 8, 2025 | — | $20.72M | — | — | -$0.15 | — | — | — |
| Q2 2025 Jun 6, 2025 | — | $18.28M | — | — | -$0.17 | — | — | — |
| Q1 2025 Mar 25, 2025 | — | $17.26M | — | -$1.40 | -$1.08 | +22.69% | — | — |
| Q4 2024 Dec 3, 2024 | — | $18.33M | — | -$1.41 | -$0.50 | +64.55% | — | — |
| Q3 2024 Aug 22, 2024 | — | $18.65M | — | -$1.49 | -$0.14 | +90.58% | — | — |
| Q2 2024 May 29, 2024 | — | $17.37M | — | -$1.52 | -$0.16 | +89.49% | — | — |
| Q1 2024 Mar 28, 2024 | $15.30M | $17.10M | +11.73% | — | -$2.20 | — | — | — |
| Q4 2023 Nov 30, 2023 | $20.13M | $17.46M | -13.26% | -$1.81 | -$2.30 | -27.25% | — | — |
| Q3 2023 Aug 31, 2023 | $20.13M | $20.19M | +0.29% | -$1.89 | -$1.80 | +4.70% | — | — |
| Q2 2023 May 30, 2023 | $20.13M | $20.73M | +2.96% | -$2.00 | -$2.60 | -30.00% | — | — |
| Q1 2023 Mar 28, 2023 | $16.30M | $20.77M | +27.45% | -$0.38 | -$3.10 | -715.79% | — | — |
| Q4 2022 Nov 15, 2022 | $21.57M | $21.64M | +0.34% | -$2.80 | -$3.10 | -10.71% | — | — |
| Q3 2022 Aug 31, 2022 | $22.68M | $19.52M | -13.93% | -$3.60 | -$3.70 | -2.78% | — | — |
| Q2 2022 May 31, 2022 | $21.82M | $21.33M | -2.24% | -$2.30 | -$3.90 | -69.57% | — | — |
| Q1 2022 Mar 21, 2022 | $21.48M | $23.14M | +7.70% | -$0.24 | -$3.80 | -1509.69% | — | — |
| Q4 2021 Nov 15, 2021 | $20.87M | $19.62M | -6.00% | -$1.90 | -$2.50 | -31.58% | — | — |
| Q3 2021 Aug 31, 2021 | — | $19.68M | — | -$1.50 | -$3.00 | -100.00% | — | — |
| Q2 2021 May 25, 2021 | — | $16.24M | — | -$1.40 | -$2.50 | -78.57% | — | — |